EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations

Cancer Genetics

Volumn 205, Issue 6, 2012, Pages 304-312

  Beck, Robert ^a   Monument, Michael J ^a,b   Watkins, W Scott ^b   Smith, Richard ^a   Boucher, Kenneth M ^b   Schiffman, Joshua D ^a,b   Jorde, Lynn B ^b   Randall, R Lor ^a,b   Lessnick, Stephen L ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Ewing sarcoma; EWS FLI; GGAA containing microsatellites; NROB1

Indexed keywords

ADENINE; GENOMIC DNA; GUANINE; MICROSATELLITE DNA; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1; CAV1 PROTEIN, HUMAN; CAVEOLIN 1; FLI1 PROTEIN, HUMAN; NR0B1 PROTEIN, HUMAN; NUCLEAR RECEPTOR DAX 1;

ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; CAV1 GENE; ETHNIC DIFFERENCE; EWING SARCOMA; GENE TARGETING; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NEGRO; NR0B1 GENE; NUCLEOTIDE REPEAT; ONCOGENE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; AFRICA; DNA BASE COMPOSITION; ETHNOLOGY; EUROPE; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; BASE COMPOSITION; CAVEOLIN 1; DAX-1 ORPHAN NUCLEAR RECEPTOR; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-FLI-1; SARCOMA, EWING;

EID: 84865079743     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.04.004     Document Type: Article

References (37)

1. Grier H.E., Krailo M.D., Tarbell N.J., et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003, 348:694-701.
2. Balamuth N.J., Womer R.B. Ewing's sarcoma. Lancet Oncol 2010, 11:184-192.
3. Randall R.L., Lessnick S.L., Jones K.B., et al. Is there a predisposition gene for Ewing's sarcoma?. J Oncol 2010, 2010:397632.
4. Cotterill S.J., Ahrens S., Paulussen M., et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000, 18:3108-3114.
5. Maheshwari A.V., Cheng E.Y. Ewing sarcoma family of tumors. J Am Acad Orthop Surg 2010, 18:94-107.
6. Jawad M.U., Cheung M.C., Min E.S., et al. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer 2009, 115:3526-3536.
7. Polednak A.P. Primary bone cancer incidence in black and white residents of New York State. Cancer 1985, 55:2883-2888.
8. Parkin D.M., Stiller C.A., Draper G.J., et al. The international incidence of childhood cancer. Int J Cancer 1988, 42:511-520.
9. Lee J., Hoang B.H., Ziogas A., et al. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 2010, 116:1964-1973.
10. Worch J., Matthay K.K., Neuhaus J., et al. Ethnic and racial differences in patients with Ewing sarcoma. Cancer 2010, 116:983-988.
11. Delattre O., Zucman J., Melot T., et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994, 331:294-299.
12. Janknecht R. EWS-ETS oncoproteins: the linchpins of Ewing tumors. Gene 2005, 363:1-14.
13. Zucman-Rossi J., Batzer M.A., Stoneking M., et al. Interethnic polymorphism of EWS intron 6: genome plasticity mediated by Alu retroposition and recombination. Hum Genet 1997, 99:357-363.
14. Zucman J., Delattre O., Desmaze C., et al. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints. Genes Chromosomes Cancer 1992, 5:271-277.
15. Plougastel B., Zucman J., Peter M., et al. Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 1993, 18:609-615.
16. Dubois S.G., Goldsby R., Segal M., et al. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the childhood cancer survivor study. Pediatr Blood Cancer 2011 Jul 25, [epub ahead of print], doi:10.1002/pbc.23263.
17. Postel-Vinay S., Veron A.S., Tirode F., et al. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 2012, 44(3):323-327.
18. Smith R., Owen L.A., Trem D.J., et al. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 2006, 9:405-416.
19. Kinsey M., Smith R., Lessnick S.L. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 2006, 4:851-859.
20. Tirode F., Laud-Duval K., Prieur A., et al. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007, 11:421-429.
21. Gangwal K., Sankar S., Hollenhorst P.C., et al. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci USA 2008, 105:10149-10154.
22. Guillon N., Tirode F., Boeva V., et al. The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS One 2009, 4:e4932.
23. Patel M., Simon J.M., Iglesia M.D., et al. Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcription. Genome Res 2011, 22(2):259-270.
24. Garcia-Aragoncillo E., Carrillo J., Lalli E., et al. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene 2008, 27:6034-6043.
25. Williams T.M., Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005, 288:C494-C506.
26. Tirado O.M., Mateo-Lozano S., Villar J., et al. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res 2006, 66:9937-9947.
27. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
28. Eckert K.A., Hile S.E. Every microsatellite is different: intrinsic DNA features dictate mutagenesis of common microsatellites present in the human genome. Mol Carcinog 2009, 48:379-388.
29. Jorde L.B., Bamshad M.J., Watkins W.S., et al. Origins and affinities of modern humans: a comparison of mitochondrial and nuclear genetic data. Am J Hum Genet 1995, 57:523-538.
30. Watkins W.S., Ricker C.E., Bamshad M.J., et al. Patterns of ancestral human diversity: an analysis of Alu-insertion and restriction-site polymorphisms. Am J Hum Genet 2001, 68:738-752.
31. McLellan T., Jorde L.B., Skolnick M.H. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984, 36:836-857.
32. Jorde L.B., Rogers A.R., Bamshad M., et al. Microsatellite diversity and the demographic history of modern humans. Proc Natl Acad Sci U S A 1997, 94:3100-3103.
33. Luo W., Gangwal K., Sankar S., et al. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Oncogene 2009, 28:4126-4132.
34. Tishkoff S.A., Dietzsch E., Speed W., et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 1996, 271:1380-1387.
35. Vigilant L., Stoneking M., Harpending H., et al. African populations and the evolution of human mitochondrial DNA. Science 1991, 253:1503-1507.
36. Toomey E.C., Schiffman J.D., Lessnick S.L. Recent advances in the molecular pathogenesis of Ewing's sarcoma. Oncogene 2010, 29:4504-4516.
37. Kovar H. Context matters: the hen or egg problem in Ewing's sarcoma. Semin Cancer Biol 2005, 15:189-196.